Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Brander who wrote (5524)	9/8/1998 1:31:00 PM
From: Linda Kaplan	Read Replies (3) \| Respond to of 7041

Brad: The article is about Viagra, not about Vasomax. That should have been clear. What I said was: if Viagra, which has been approved in US and UK, is restricted to being not covered by their national health service, than Vasomax would logically follow the same path, or a more restricted path, since it's not even approved in the US. We know it hasn't been approved in UK, of course. It has only applied for approval in UK. But if it were approved in UK, it would not likely be given a more liberal play than Viagra, since Viagra was approved in the US and Vasomax has not been approved in the US. Do you have any concrete examples with which to argue with that reasoning? Did you go long ZONA? Linda